ISRG SVP reports RSU vesting and tax share withholding

Intuitive Surgical (ISRG) senior vice president Iman Jeddi reported routine equity vesting and tax withholding transactions.

Rhea-AI Filing Summary

Intuitive Surgical (ISRG) senior vice president Iman Jeddi reported routine equity vesting and tax withholding transactions. On February 10, 2026, 838 restricted stock units granted on February 10, 2023 converted into 838 shares of common stock at an exercise price of $0.0.

A portion of these shares—309—was automatically withheld at a value of $492.84 per share to cover statutory taxes, leaving 585 shares held directly after the transactions. In addition, 26,649 shares of Intuitive Surgical common stock are reported as held indirectly by a trust associated with the reporting person. The RSU award vests 25% annually over four years, with each vested RSU converting into one share of common stock.

Insider Trade Summary

838 shares exercised/converted

Exercise 4 txns

Insider Jeddi Iman

Role SVP & GM da Vinci Platforms &

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units - 2-28-2023	838	$0.00	$0.00
Exercise	Common Stock	838	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	309	$492.84	$152K
holding	Common Stock	--	--	--

Holdings After Transaction: Restricted Stock Units - 2-28-2023 — 838 contracts (Direct); Common Stock — 585 shares (Direct); Common Stock — 26,649 shares (Indirect, by Trust)

Footnotes (2)

1. F1. RSUs vest 25% per year over a four year period, commencing on each anniversary of February 10, 2023. RSUs convert into common stock on the vest date on a one-for-one basis. 25% of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.
2. F2. Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock upon vesting. 25% of the RSUs shall vest on each anniversary of February 10, 2023, subject to Reporting Person's continuous service to the Issuer through each such vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did ISRG executive Iman Jeddi report on this Form 4?

ISRG executive Iman Jeddi reported vesting of 838 restricted stock units that converted into common shares. On the same date, 309 of those shares were withheld at a set value to satisfy statutory tax obligations, leaving 585 shares held directly after the transactions.

How do the reported RSUs for ISRG vest for executive Iman Jeddi?

The RSUs reported for ISRG executive Iman Jeddi vest 25% each year over four years starting February 10, 2023. Each vested restricted stock unit converts into one share of Intuitive Surgical common stock, subject to the executive’s continued service through each vesting date.

How many ISRG shares were used to cover taxes in this Form 4 filing?

The filing shows that 309 shares of Intuitive Surgical common stock were withheld to cover statutory tax withholding. These shares came from the 838 RSUs that vested and converted into common stock on February 10, 2026, reducing the net shares retained directly.

How many ISRG shares does Iman Jeddi hold directly and indirectly after the reported transactions?

After the reported transactions, Iman Jeddi directly holds 585 shares of Intuitive Surgical common stock. The Form 4 also reports 26,649 ISRG shares held indirectly by a trust, reflecting additional beneficial ownership separate from the directly owned shares.

What is the exercise or conversion price of the RSUs reported for ISRG in this Form 4?

The restricted stock units reported for ISRG have an exercise or conversion price of $0.0 per unit. Upon vesting, each RSU automatically converts into one share of Intuitive Surgical common stock without additional cash payment from the reporting person.

What role does Iman Jeddi hold at Intuitive Surgical (ISRG) in this insider filing?

In this insider filing, Iman Jeddi is identified as an officer of Intuitive Surgical with the title "SVP & GM da Vinci Platforms &". This indicates a senior leadership role overseeing the company’s da Vinci surgical platforms business area.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/10/2026 - 03:26 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jeddi Iman

(Last) (First) (Middle)

1020 KIFER ROAD

(Street)

SUNNYVALE CA 94086

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
INTUITIVE SURGICAL INC [ ISRG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP & GM da Vinci Platforms &

3. Date of Earliest Transaction (Month/Day/Year)
02/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/10/2026		M(1)		838	A	$0.0	894	D
Common Stock	02/10/2026		F(1)		309	D	$492.84	585	D
Common Stock								26,649	I	by Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units - 2-28-2023	$0.0	02/10/2026		M			838	(2)	(2)	Common Stock	838	$0.0	838	D

Explanation of Responses:

1. RSUs vest 25% per year over a four year period, commencing on each anniversary of February 10, 2023. RSUs convert into common stock on the vest date on a one-for-one basis. 25% of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

2. Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock upon vesting. 25% of the RSUs shall vest on each anniversary of February 10, 2023, subject to Reporting Person's continuous service to the Issuer through each such vesting date.

	By: Stephanie Lim-Ignacio For: Jeddi, Iman	02/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.